Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same

Details for Australian Patent Application No. 2003278249 (hide)

Owner Aventis Pharma S.A.

Inventors Detruc-Rosset, Gilles; Babin, Didier; Lesuisse, Dominique; Rooney, Thomas; Halley, Franck

Agent Watermark

Pub. Number AU-B-2003278249

PCT Number PCT/FR03/02633

PCT Pub. Number WO2004/022544

Priority 60/419,965 22.10.02 US; 02/10962 05.09.02 FR

Filing date 3 September 2003

Wipo publication date 29 March 2004

Acceptance publication date 16 September 2010

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 60/419,965 22.10.02 US; 02/10962 05.09.02 FR

13 May 2004 Application Open to Public Inspection

  Published as AU-B-2003278249

16 September 2010 Application Accepted

  Published as AU-B-2003278249

28 October 2010 Application for Amendment

  The nature of the amendment is: Amend co-inventor name from Detruc-Rosset, Gilles to Dutruc-Rosset, Gilles. Address for service in Australia - Watermark Patent and Trade Marks Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122 2005

18 November 2010 Corrigenda

  Applications Accepted - Name Index Under the name Aventis Pharma S.A., Application No. 2003278249, under INID (72) correct the co-inventor to DutrucRosset, Gilles

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278250-Aminoindazole derivatives and use thereof as kinase inhibitors

2003278248-DIFFUSING SUBSTRATE